๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for neuroblastoma

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma NCT02605421Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Thiotepa, Cyclophosphamide, Melphalan, Etoposide, Carboplatin Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate 18F-DOPA II - PET Imaging Optimization NCT04706910Phase 31 site๐Ÿ“ Edmonton University of Alberta ยท Tests: 18F-DOPA, Furosemide Injection Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma NCT07516678n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Alectinib Study in Children and Adolescents of 177Lu-DOTATATE (Lutatheraยฎ) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site๐Ÿ“ Boadilla del Monte Fundaciรณn de investigaciรณn HM ยท Tests: Olaparib; 177Lu-DOTATATE Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma NCT07027748Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Steven DuBois, MD ยท Tests: Naxitamab, Irinotecan, Temozolomide, Sargramostim granulocyte-macrophage colony stimulating factor Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma NCT05489887Phase 226 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Oakland Giselle Sholler ยท Tests: Naxitamab Pediatric Precision Laboratory Advanced Neuroblastoma Therapy NCT02559778Phase 228 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Oakland Giselle Sholler ยท Tests: Ceritinib, dasatinib, sorafenib, vorinostat, DFMO Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Becotatug Vedotin Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma NCT00107289Phase 21 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: iobenguane I 131 TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma NCT05562024Phase 12 sites๐Ÿ“ Jinan๐Ÿ“ Tianjin PersonGen BioTherapeutics (Suzhou) Co., Ltd. ยท Tests: T cell injection targeting B7-H3 chimeric antigen receptor Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma NCT07375563Phase 31 site๐Ÿ“ Moscow Federal Research Institute of Pediatric Hematology, Oncologโ€ฆ ยท Tests: Dinutuximab beta, temozolomide, irinotecan, autologous NK cell, irinotecan, temozolomide, dinutuximab beta, NK-cell proโ€ฆ APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors NCT05701306Phase 1, Phase 23 sites๐Ÿ“ Guangzhou๐Ÿ“ Wuhan๐Ÿ“ Tianjin Ascentage Pharma Group Inc. ยท Tests: APG-115, APG-2575 A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients NCT07549321Phase 2, Phase 319 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Chicago Renaissance Pharma Ltd. ยท Tests: hu1418K322A + Temozolomide + Irinotecan Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma NCT07767630EARLY Phase 11 site๐Ÿ“ Chengdu Sichuan University ยท Tests: [211At]MABG Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method NCT07141862n/a1 site๐Ÿ“ Clermont-Ferrand University Hospital, Clermont-Ferrand ยท Tests: RT-qPCR, ddPCR Engineering Immune Organoids to Study Pediatric Cancer NCT05890781NA2 sites๐Ÿ“ Villejuif๐Ÿ“ Paris Gustave Roussy, Cancer Campus, Grand Paris ยท Tests: Skin biopsy, Fresh tumor sample, Blood sample, Healthy tissue from the tumor, Spinal cerebrospinal fluid (SCF) Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma NCT06013618Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen University Cancer Center ยท Tests: Naxitamab monotherapy, GM-CSF, Irinotecan, Temozolomide, Naxitamab in combination therapy Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma NCT07064746n/a1 site๐Ÿ“ Nanjing Nanjing First Hospital, Nanjing Medical University ยท Tests: ยนยฒยณI-MIBG SPECT/CT, SSTR PET A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites๐Ÿ“ Birmingham๐Ÿ“ Aurora๐Ÿ“ Washington D.C. Nationwide Children's Hospital ยท Tests: Cabozantinib Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors NCT05608148Phase 11 site๐Ÿ“ Fukuoka Kyushu University ยท Tests: Biological, Biological, Biological, Biological NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial NCT06450041Phase 213 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Aurora New Approaches to Neuroblastoma Therapy Consortium ยท Tests: Universal Donor (UD) TGFฮฒi NK Cells, Temozolomide, Irinotecan, Dinutuximab, GM-CSF Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors NCT02013336Phase 15 sites๐Ÿ“ Cincinnati๐Ÿ“ Oklahoma City๐Ÿ“ Dallas South Plains Oncology Consortium ยท Tests: MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome NCT00588068n/a1 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: Tumor and Marrow Markers SPEARHEAD-3 Pediatric Study NCT05642455Phase 1, Phase 210 sites๐Ÿ“ Palo Alto๐Ÿ“ Bethesda๐Ÿ“ Boston USWM CT, LLC ยท Tests: Afamitresgene autoleucel Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma NCT07067346EARLY Phase 12 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu Sichuan University ยท Tests: IR-101 Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies NCT01109394n/a5 sites๐Ÿ“ Washington D.C.๐Ÿ“ Orange๐Ÿ“ Bethesda National Cancer Institute (NCI) Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation NCT06942039EARLY Phase 112 sites๐Ÿ“ Calgary๐Ÿ“ Vancouver๐Ÿ“ Winnipeg C17 Council ยท Tests: Cytarabine IT, hydrocortisone, Cisplatin, Vincristine, Etoposide Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190Phase 1, Phase 21 site๐Ÿ“ Gainesville University of Florida ยท Tests: Miltenyi CliniMACS Prodigy ยฎ system, Zoledronic acid
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy